
Precipio PRPO
€ 22.54
1.64%
Geschäftsbericht 2025
hinzugefügt 30.03.2026
Precipio Langfristiger Schuldenstrom 2011-2026 | PRPO
Langfristiger Schuldenstrom Jährlich Precipio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 410 K | 201 K | 218 K | 199 K | 166 K | 225 K | 209 K | 263 K | 587 K | 7.81 M | 7.6 M | 462 K | 242 K | 6.17 M | 3.7 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.81 M | 166 K | 1.9 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 168.22 | -3.26 % | $ 8.34 B | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 24.73 | -0.44 % | $ 687 M | ||
|
Danaher Corporation
DHR
|
199 M | $ 192.12 | 0.53 % | $ 137 B | ||
|
DexCom
DXCM
|
21.6 M | $ 63.21 | 1.59 % | $ 24.7 B | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 16.42 | -2.38 % | $ 496 M | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Guardant Health
GH
|
27.7 M | $ 89.66 | -4.44 % | $ 11.2 B | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 109.62 | -4.0 % | $ 9.04 B | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 17.82 | -2.68 % | $ 950 M | ||
|
Illumina
ILMN
|
79 M | $ 127.74 | 0.28 % | $ 20.3 B | ||
|
IQVIA Holdings
IQV
|
93 M | $ 170.72 | -1.47 % | $ 29.3 B | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 274.46 | 0.27 % | $ 22.8 B | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 75.89 | -0.28 % | $ 5.12 B | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 496.0 | -0.47 % | $ 14.3 B | ||
|
Mettler-Toledo International
MTD
|
35.1 M | $ 1 266.63 | 0.53 % | $ 26.1 B | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 4.67 | -1.68 % | $ 432 M | ||
|
ENDRA Life Sciences
NDRA
|
129 K | $ 4.74 | 1.07 % | $ 3.73 M | ||
|
NeoGenomics
NEO
|
4.78 M | $ 8.02 | 0.25 % | $ 1.03 B | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 9.56 | 1.59 % | $ 2.07 B | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
451 K | $ 17.33 | 0.99 % | $ 388 M | ||
|
Natera
NTRA
|
7.64 M | $ 204.87 | -1.5 % | $ 20.2 B | ||
|
Biodesix
BDSX
|
719 K | $ 15.36 | 1.92 % | $ 1.99 B | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Pacific Biosciences of California
PACB
|
448 K | $ 1.42 | 5.97 % | $ 426 M | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 27.2 | 0.33 % | $ 20 B | ||
|
Personalis
PSNL
|
7.7 M | $ 6.58 | - | $ 390 M | ||
|
RadNet
RDNT
|
61.9 M | $ 55.06 | 0.49 % | $ 4.14 B | ||
|
Senseonics Holdings
SENS
|
496 K | $ 6.69 | -3.04 % | $ 279 M | ||
|
Sotera Health Company
SHC
|
5.76 M | $ 14.87 | -0.6 % | $ 4.22 B | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Soleno Therapeutics
SLNO
|
726 K | $ 52.25 | 32.31 % | $ 2.66 B | ||
|
Neuronetics
STIM
|
5.56 M | $ 1.76 | 15.79 % | $ 116 M | ||
|
Thermo Fisher Scientific
TMO
|
275 M | $ 488.19 | -0.67 % | $ 184 B |